Skip to content
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) Investor Forum, one of the only independent partnering events dedicated to […]
How to follow the 2024 BIO Investor Forum in San Francisco Read More »
As climate change threatens crops and shifts growing areas, maintaining food security requires the kinds of improvements to plant and animal farming that biotech
Biotech bolsters food security amid climate challenges: I am BIO Podcast Read More »
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve policy that impacts the
What to know about BIO’s 7 Core Strategic Priorities Read More »
Sustainable aviation fuel (SAF) uses the power of biology to launch airliners. A group of senators said they will use their legislative power to
Senate Sustainable Aviation Caucus to back pro-SAF legislation Read More »
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security.
American leadership in biotechnology is a vital national security asset in need of protection now, and its importance can be expected to grow in
I am BIO Podcast: Biotechnology is national security technology Read More »
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
In the season opener of the I am BIO Podcast, Dr. David Fajgenbaum shares his journey from patient to scientist, explaining how his battle
I am BIO Podcast: How Dr. David Fajgenbaum saved his own life Read More »
As authorities reveal 19 people at a California music festival contracted Valley fever, a company making a Valley fever vaccine for dogs is set
What to know about Valley fever vaccine development Read More »
Neuroene Therapeutics is developing mitochondrial-protective small molecules for epilepsy, Parkinson’s, and mitochondrial diseases. The company’s CEO Sherine Chan, Ph.D., co-founded Neuroene with medicinal chemist
BIO Start-Up Stadium 2024: Meet Emerging Company winner Neuroene Therapeutics Read More »
